Curious Cure: Human Waste

Studies point to the life-saving record of fecal transplants for patients infected with C. diff, despite a recent death. Doctors are now testing the procedure for other conditions.

Written byKendall Powell
| 8 min read
fmt fecal matter transplant c. difficile microbiome

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

ABOVE: AP PHOTO / STEPHEN SENNE

In 2008, gastroenterologist Colleen Kelly had a patient with a recurring and debilitating infection of the gut with a microbe called Clostridioides difficile. Nothing Kelly did could ease the woman’s severe abdominal cramping and diarrhea.

So Kelly—at her patient’s urging—decided to try something highly experimental: transplanting a fecal sample from a healthy donor into the large intestine. And it worked.

Kelly, of Brown University School of Medicine in Providence, Rhode Island, is now one of the leading doctors performing the procedure. She has done about 300 fecal transplants in the last decade, with good success—and has even, she says, seen ICU patients with the most severe form of the infection sit up and ask for food within a day of their transplant.

Today’s data show that fecal transplants cure 80 percent to 90 percent of patients with recurrent C. diff infections—and doctors across the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies